Progressive vaccinia: Case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001

Journal of Infectious Diseases

Volumn 206, Issue 9, 2012, Pages 1372-1385

  Lederman, Edith R ^a,c   Davidson, Whitni ^a   Groff, Harold L ^c   Smith, Scott K ^a   Warkentien, Tyler ^b   Li, Yu ^a   Wilkins, Kimberly A ^a   Karem, Kevin L ^a   Akondy, Rama S ^b   Ahmed, Rafi ^b   Frace, Michael ^a   Shieh, Wun Ju ^a   Zaki, Sherif ^a   Hruby, Dennis E ^d   Painter, Wendy P ^e   Bergman, Kimberly L ^f   Cohen, Jeffrey I ^g   Damon, Inger K ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAN DIEGO STATE UNIVERSITY   (United States)

^d SIGA Technologies Incorporated   (United States)

^e Chimerix   (United States)

^f CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^g NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR 3 HEXADECYLOXYPROPYL ESTER; CORTICOSTEROID; CYTARABINE; DEOXYRIBONUCLEASE I; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SMALLPOX VACCINE; TECOVIRIMAT; VACCINIA ANTIBODY; VANCOMYCIN; VIRUS DNA;

ABSENCE OF SIDE EFFECTS; ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; AMINO ACID SUBSTITUTION; ANTIBODY TITER; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; BACTERIAL SUPERINFECTION; CANCER CHEMOTHERAPY; CASE REPORT; CELLULAR IMMUNITY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; F13L GENE; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOCOMPROMISED PATIENT; IMMUNOHISTOCHEMISTRY; INJECTION SITE VESICLE; MALE; MASS SPECTROMETRY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NEUTROPENIA; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE VACCINIA; PUNCH BIOPSY; SAILOR; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN BIOPSY; VACCINIA; VACCINIA VIRUS; VIRUS EXAMINATION; VIRUS GENE;

ADULT; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; BENZAMIDES; CYTOSINE; DRUG RESISTANCE, VIRAL; HUMANS; IMMUNOGLOBULINS; ISOINDOLES; MALE; ORGANOPHOSPHONATES; SMALLPOX VACCINE; TREATMENT OUTCOME; VACCINIA; VACCINIA VIRUS;

EID: 84867543892     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis510     Document Type: Article

References (22)

1. World Health Organization. Declaration of global eradication of smallpox. Wkly Epidemiol Rec 1980; 55:145-52.
2. Henderson DA, Inglesby TV, Bartlett JG, et al. Smallpox as a biological weapon: Medical and public health management. Working Group on Civilian Biodefense. JAMA 1999; 281:2127-37. (Pubitemid 29264692)
3. Reynolds MG, Yorita KL, Kuehnert MJ, et al. Clinical manifestations of human monkeypox influenced by route of infection. J Infect Dis 2006; 194:773-80. (Pubitemid 44344124)
4. Hammarlund E, Lewis MW, Hansen SG, et al. Duration of antiviral immunity after smallpox vaccination. Nat Med 2003; 9:1131-7. (Pubitemid 37173696)
5. Karem K, Reynolds M, Hughes C, et al. Monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection. Clin Vaccine Immunol 2007; 14:1318-27. (Pubitemid 350012975)
6. Cono J, Casey C, Bell DM. Smallpox vaccination and adverse reactions. Morb Mortal Wkly Rep 2003; 52:1-28.
7. Centers for Disease Control and Prevention. Household transmission of vaccinia virus from contact with a military smallpox vaccine. Morb Mortal Wkly Rep 2007; 56:471-81.
8. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968. N Engl J Med 1969; 281:1201-8.
9. Vora S, Damon I, Fulginiti V, et al. Severe eczema vaccinatum in a household contact of a smallpox vaccinee. Clin Infect Dis 2008; 46:1555-61. (Pubitemid 351706737)
10. Li Y, Olson VA, Laue T, Laker MT, Damon IK. Detection of monkeypox virus with real-time PCR assays. J Clin Virol 2006; 36:194-203. (Pubitemid 43884809)
11. Karem KL, Reynolds M, Braden Z, et al. Characterization of acutephase humoral immunity to monkeypox: Use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak. Clin Diagn Lab Immunol 2005; 12:867-72. (Pubitemid 40993288)
12. Miller JD, van der Most RG, Akondy RS, et al. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 2008; 28:710-22.
13. Guarner J, Johnson BJ, Paddock CD, et al. Monkeypox transmission and pathogenesis in prairie dogs. Emerg Infect Dis 2004; 10:426-31. (Pubitemid 38314467)
14. Nell P, Kohl KS, Graham PL, et al. Progressive vaccinia as an adverse event following exposure to vaccinia virus: Case definition and guidelines of data collection, analysis, and presentation of immunization safety data. Vaccine 2007; 25:5735-44. (Pubitemid 47049770)
15. Terajima M, Cruz J, Raines G, et al. Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses. J Exp Med 2003; 197:927-32. (Pubitemid 36437869)
16. Chng WJ, Tan GB, Kuperan P. Establishment of adult peripheral blood lymphocyte subset reference range for an Asian population by single-platform flow cytometry: Influence of age, sex, and race and comparison with other published studies. Clin Diagn Lab Immunol 2004; 11:168-73. (Pubitemid 38090672)
17. Yang G, Pevear DC, Davies MH, et al. An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge. J Virol 2005; 79:13139-49. (Pubitemid 41433232)
18. Bray M, Wright ME. Progressive vaccinia. Clin Infect Dis 2003; 36:766-74. (Pubitemid 36337981)
19. Lustig S, Fogg C, Whitbeck JC, Eisenberg RJ, Cohen GH, Moss B. Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge. J Virol 2005; 79:13454-62. (Pubitemid 41508158)
20. Human vaccinia infection after contact with a raccoon rabies vaccine bait-Pennsylvania, 2009. MMWR Morb Mortal Wkly Rep 2009; 58:1204-7.
21. Quenelle DC, Prichard MN, Keith KA, et al. Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses. Antimicrob Agents Chemother 2007; 51:4118-24. (Pubitemid 350057813)
22. Chen N, Bellone CJ, Schriewer J, et al. Poxvirus interleukin-4 expression overcomes inherent resistance and vaccine-induced immunity: Pathogenesis, prophylaxis, and antiviral therapy. Virology 2011; 409:328-37.